Detalles de la búsqueda
1.
Real-world biologic and apremilast treatment patterns in patients with psoriasis and psoriatic arthritis.
Dermatol Online J
; 27(9)2021 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34755976
2.
Real-world biologic and apremilast treatment patterns and healthcare costs in moderate-to-severe plaque psoriasis.
Dermatol Online J
; 27(1)2021 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33560784
3.
Potential drug-drug and drug-condition interactions among fibromyalgia patients initiating pregabalin or duloxetine: prevalence and health care expenditure impact.
Pain Med
; 15(8): 1282-93, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24401017
4.
Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status.
J Dermatolog Treat
; 32(2): 203-211, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31769703
5.
Cost comparison of drug-drug and drug-condition interactions in patients with painful diabetic peripheral neuropathy treated with pregabalin versus duloxetine.
Am J Health Syst Pharm
; 70(24): 2207-17, 2013 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24296843
Resultados
1 -
5
de 5
1
Próxima >
>>